世界卫生组织III级肥胖队列中的视网膜病变:患病率与危险因素
在曼海姆肥胖研究中,277名18-64岁世界卫生组织III级肥胖受试者接受横断面视网膜病变筛查,视网膜病变患病率为6.5%;合并糖尿病者患病率为16.7%,无糖尿病者为3.4%。存在糖尿病使视网膜病变风险增加8.3倍(OR 8.3,95%CI 1.01至67.49),而闪烁光诱发的视网膜静脉扩张每增加一个百分点,风险降低近50%(OR 0.54,95%CI 0.30至0.95)。
要点
- 世界卫生组织III级肥胖队列中视网膜病变患病率为6.5%(18/277)。
- 合并糖尿病者视网膜病变患病率为16.7%,无糖尿病者为3.4%。
- 糖尿病使视网膜病变风险增加8.3倍(OR 8.3,95%CI 1.01至67.49)。
核心结论
- 本世界卫生组织III级肥胖队列中视网膜病变患病率低。
- 糖尿病的存在是视网膜病变最重要的危险因素。
- 保留的静脉功能提示对 retinal 病变具有保护作用。
研究设计与样本
- 曼海姆肥胖研究为横断面研究,纳入277名18-64岁世界卫生组织III级肥胖受试者。
- 采用三视野视网膜摄影筛查视网膜病变。
- 通过小动脉-小静脉比值和闪烁光分析评估内皮功能。
- 比较有和无视网膜病变受试者的人体测量学、代谢、血管和肾脏参数。
主要发现
- 277名受试者中18名(6.5%)发现视网膜病变。
- 合并糖尿病者视网膜病变患病率为16.7%,无糖尿病者为3.4%。
- 有和无视网膜病变者之间糖尿病患病率(61.1% vs 21.7%,p<0.001)、收缩压(145.56 vs 131.73 mm Hg,p=0.005)、内膜-中膜厚度(0.7 vs 0.59 mm,p=0.034)、闪烁光诱发的视网膜静脉扩张(2.24% vs 4.28%,p=0.004)和肌酐(0.92 vs 0.83 mg/dL,p=0.011)存在显著差异。
- 逐步逻辑回归分析显示,糖尿病的存在使视网膜病变风险增加8.3倍(OR 8.3,p=0.049,95%CI 1.01至67.49)。
- 闪烁光诱发的静脉扩张每增加一个百分点,视网膜病变风险降低近50%(OR 0.54,p=0.032,95%CI 0.30至0.95)。
关键数值与推荐
- 视网膜病变患病率:总体6.5%(18/277),合并糖尿病者16.7%,无糖尿病者3.4%。
- 糖尿病与视网膜病变的OR为8.3(p=0.049,95%CI 1.01至67.49)。
- 闪烁光诱发静脉扩张每增加1%的OR为0.54(p=0.032,95%CI 0.30至0.95)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess retinopathy and its risk factors in an obesity WHO III cohort. METHODS: In the Mannheim Obesity Study, 277 subjects with obesity WHO III aged 18-64 years were examined in a cross-sectional approach. Screening for retinopathy was performed using 3-field retinal photography. Endothelial function was assessed using arteriole-to-venule ratio and flicker light analysis. Subjects with and without retinopathy were analysed for anthropometry, metabolic, vascular and renal parameters. RESULTS: Retinopathy was found in 18 of the 277 subjects (6.5%). Prevalence of retinopathy was 16.7% in subjects with and 3.4% in subjects without diabetes mellitus. Between subjects with and without retinopathy there were significant differences in diabetes prevalence (61.1% vs 21.7%, p<0.001), systolic blood pressure (145.56 vs 131.73 mm Hg, p=0.005), intima-media thickness (0.7 vs 0.59 mm, p=0.034), dilatation of retinal veins in response to flicker light (2.24% vs 4.28%, p=0.004) and creatinine (0.92 vs 0.83 mg/dL, p=0.011). Stepwise logistic regression analysis revealed that the presence of diabetes mellitus led to an 8.3-fold increased risk for retinopathy (OR 8.3, p=0.049, 95% CI 1.01 to 67.49), whereas risk for retinopathy decreased by nearly 50% (OR 0.54, p=0.032, 95% CI 0.30 to 0.95) with each percentage increase in venous dilatation in response to flicker light. CONCLUSIONS: Retinopathy prevalence in our obesity WHO III cohort is low. Presence of diabetes mellitus is the most important risk factor for retinopathy. Preserved venular function indicates protection from retinopathy. TRIAL REGISTRATION NUMBER: NCT00770276, Results.
引用
- Mattern J, Lammert A, Otto M, et al. Retinopathy in an obesity WHO III cohort: prevalence and risk factors. Br J Ophthalmol. 2017. PMID: 28314833. doi:10.1136/bjophthalmol-2016-309566
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。